Am J Perinatol 2015; 32(03): 277-282
DOI: 10.1055/s-0034-1383851
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Oscillometric and Intra-arterial Blood Pressure in Preterm and Term Infants: Extent of Discrepancy and Factors Associated with Inaccuracy

Tomoyuki Shimokaze
1   Department of Pediatrics, Saiseikai Yamagata Hospital, Yamagata, Japan
,
Kazuhiro Akaba
1   Department of Pediatrics, Saiseikai Yamagata Hospital, Yamagata, Japan
,
Emi Saito
1   Department of Pediatrics, Saiseikai Yamagata Hospital, Yamagata, Japan
› Author Affiliations
Further Information

Publication History

16 March 2014

27 May 2014

Publication Date:
27 June 2014 (online)

Zoom Image

Abstract

Objective Securing an arterial line to monitor continuous blood pressure (BP) is difficult in infants. We aimed to reveal the extent of discrepancies between oscillometric and direct BP.

Study Design Infants who required continuous BP monitoring were prospectively enrolled. Direct and indirect BP were simultaneously recorded. Disposable BP cuffs matching one-half to two-thirds of the upper arm circumference were used.

Results A total of 74 infants were studied (gestational age [GA], 24–42 weeks). The correlation coefficients of systolic, diastolic, and mean arterial BP of indirect and direct measurements were 0.87, 0.82, and 0.84, respectively (p < 0.001). The mean differences in systolic, diastolic, and mean arterial BP (indirect minus direct BP) were 2.2 ± 5.7, − 6.0 ± 5.8, and − 1.3 ± 5.7 mm Hg, respectively. Oscillometric measurements significantly underestimated systolic BP in light-for-gestational-age infants and diastolic BP in infants without fentanyl administration. There were no significant correlations between discrepant BP measurements and edema, vasopressor administration, arterial line location, GA, postnatal age, body weight, pulse rate, or hemoglobin level. In 4.1% of infants, systolic BP increased by 10 to 15 mm Hg at the time of cuff expansion.

Conclusion We recommend intra-arterial BP measurement when the BP values seriously influence the therapeutic protocol.